Christophe Van Damme, vice president and general manager of Perrigo Belgium and Luxembourg, shines a light on the transformation for Perrigo since its acquisition of Omega Pharma in 2015. Van Damme also explains Perrigo’s strategy for growth, the impact, opportunities, and challenges of the COVID-19 crisis, and how the self-care company differentiates itself within the consumer health industry.
I predict that some of the changes in consumer preferences will remain after the pandemic ends. Therefore, we as an organisation need to be ready for the shape of this ‘new normal'
